Using scenario tree modelling for targeted herd sampling to substantiate freedom from disease
BMC Veterinary Research, ISSN: 1746-6148, Vol: 7, Issue: 1, Page: 49
2011
- 21Citations
- 73Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations21
- Citation Indexes19
- 19
- CrossRef17
- Policy Citations2
- Policy Citation2
- Captures73
- Readers73
- 73
Article Description
In order to optimise the cost-effectiveness of active surveillance to substantiate freedom from disease, a new approach using targeted sampling of farms was developed and applied on the example of infectious bovine rhinotracheitis (IBR) and enzootic bovine leucosis (EBL) in Switzerland. Relevant risk factors (RF) for the introduction of IBR and EBL into Swiss cattle farms were identified and their relative risks defined based on literature review and expert opinions. A quantitative model based on the scenario tree method was subsequently used to calculate the required sample size of a targeted sampling approach (TS) for a given sensitivity. We compared the sample size with that of a stratified random sample (sRS) with regard to efficiency.Results: The required sample sizes to substantiate disease freedom were 1,241 farms for IBR and 1,750 farms for EBL to detect 0.2% herd prevalence with 99% sensitivity. Using conventional sRS, the required sample sizes were 2,259 farms for IBR and 2,243 for EBL. Considering the additional administrative expenses required for the planning of TS, the risk-based approach was still more cost-effective than a sRS (40% reduction on the full survey costs for IBR and 8% for EBL) due to the considerable reduction in sample size.Conclusions: As the model depends on RF selected through literature review and was parameterised with values estimated by experts, it is subject to some degree of uncertainty. Nevertheless, this approach provides the veterinary authorities with a promising tool for future cost-effective sampling designs. © 2011 Blickenstorfer et al; licensee BioMed Central Ltd.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=80051650132&origin=inward; http://dx.doi.org/10.1186/1746-6148-7-49; http://www.ncbi.nlm.nih.gov/pubmed/21843367; https://bmcvetres.biomedcentral.com/articles/10.1186/1746-6148-7-49; https://www.zora.uzh.ch/id/eprint/55910; https://dx.doi.org/10.1186/1746-6148-7-49; http://dx.doi.org/10.5167/uzh-55910; https://dx.doi.org/10.5167/uzh-55910; https://www.zora.uzh.ch/id/eprint/55910/; https://www.zora.uzh.ch/id/eprint/55910/1/PU0484.pdf; https://bmcvetres.biomedcentral.com/counter/pdf/10.1186/1746-6148-7-49; http://europepmc.org/abstract/med/21843367; http://europepmc.org/articles/PMC3170209; http://www.biomedcentral.com/1746-6148/7/49; http://bmcvetres.biomedcentral.com/articles/10.1186/1746-6148-7-49
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know